首页> 外文OA文献 >Impact of the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct on medical device physician-industry collaboration
【2h】

Impact of the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct on medical device physician-industry collaboration

机译:马萨诸塞州制药和医疗器械制造商行为准则对医疗器械医生 - 行业合作的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct (PCOC) or 105 CMR 970.000 was enacted by the Massachusetts state legislature and adopted by the Department of Public Health (DPH) in July 2009 under Chapter 305 of the Acts of 2008, An Act To Promote Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care. The state law requires pharmaceutical and medical device manufacturers to comply with a marketing code of conduct, obey specific compliance activities, and disclose payments to Massachusetts-licensed healthcare providers with a value of $50 or more in connection with sales and marketing activities. This thesis qualitatively assessed the impact of 105 CMR 970.000 on physician-industry collaboration related to technology development and physician education in the Massachusetts medical device industry, as depicted by academic physicians and representatives of medical device companies during the first quarter of calendar year 2010. A pilot study comprising interviews and surveys of stakeholders in the Massachusetts medical device industry was conducted to summarize the initial impressions of the impact of 105 CMR 970.000 on medical device physician-industry collaboration, with the intention of creating a roadmap for future analysis. Informal interviews (36) included individuals at medical device manufacturers, distributors, academic medical centers, venture capital firms, law firms, consulting firms, MassMedic, and the DPH. Formal surveys (40) included academic physicians and medical device company representatives selling to Massachusetts licensed physicians. The hypothesis was confirmed that 105 CMR 970.000 has impaired medical device physician-industry collaboration related to technology development and physician education in Massachusetts. Our results may have state and federal regulatory implications for the medical device industry and can serve as a guide for future analysis.
机译:《马萨诸塞州医药和医疗设备制造商行为准则》(PCOC)或105 CMR 970.000由马萨诸塞州州立法机构制定,并由公共卫生部(DPH)于2009年7月根据2008年法令第305章通过,促进提供优质医疗保健的成本控制,透明度和效率。州法律要求制药和医疗器械制造商遵守市场营销行为守则,遵守特定的合规性活动,并向销售和营销活动涉及的马萨诸塞州许可的医疗保健提供者披露价值不低于50美元的款项。本论文定性评估了105 CMR 970.000对马萨诸塞州医疗器械行业中与技术开发和医师教育相关的医师-行业协作的影响,如2010日历年第一季度的学术医师和医疗器械公司代表所描绘的。进行了一项包括对马萨诸塞州医疗器械行业利益相关者进行访谈和调查的试点研究,以总结105 CMR 970.000对医疗器械医师与行业合作的影响的初步印象,目的是为将来的分析创建路线图。非正式采访(36)包括医疗设备制造商,分销商,学术医疗中心,风险投资公司,律师事务所,咨询公司,MassMedic和DPH的人员。正式调查(40)包括学术医师和销售给马萨诸塞州持照医师的医疗设备公司代表。证实了这一假设,即105 CMR 970.000损害了与马萨诸塞州的技术开发和医师教育有关的医疗器械医师-行业合作。我们的结果可能会对医疗器械行业产生州和联邦法规的影响,并可以用作将来分析的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号